1-7 of 7
Diego Cadavid
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prevalence of Chronic Neutropenic Disorders in the United States: A Retrospective Analysis of a Large Claims Database

Kylle M. Tollefsen, Lori Neri, Shariq Ali, Diego Cadavid
Journal: Blood
Blood (2022) 140 (Supplement 1): 5473–5474.
https://doi.org/10.1182/blood-2022-156177
Published: 2022
Journal Articles

Mavorixafor for Patients with Chronic Neutropenic Disorders: Results from a Phase 1b, Open-Label, Multicenter Study

Julia T. Warren, Kelly J. Walkovich, Audrey Anna Bolyard, Kathryn E. Dickerson, Jolan E. Walter, Diego Cadavid, Eloisa Chapa, Kelly Chen, Richard MacLeod, Katie Peters, Richard Polisson, David C. Dale
Journal: Blood
Blood (2022) 140 (Supplement 1): 1408–1410.
https://doi.org/10.1182/blood-2022-156216
Published: 2022
Journal Articles

Global Phase 3, Randomized, Placebo-Controlled Trial with Open-Label Extension Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients with WHIM Syndrome (4WHIM): Trial Design and Enrollment

David C. Dale, Laia Alsina, Antoine Azar, Raffaele Badolato, Ashish Bhandari, Andrea Belschner, Yves Bertrand, Diego Cadavid, Kathryn E. Dickerson, Navid Ezra, Henrik Hasle, Harold Hoffman, Honghua Jiang, Hyoung Jin Kang, Sorena Kiani-Alikhan, Taco W. Kuijpers, Aleksandr D. Kulagin, Daman Langguth, Carina Levin, Richard MacLeod, Olaf Neth, Jane Peake, Yulia Rodina, Anjali Sharathkumar, Anna Shcherbina, Weihua Tang, Matthias G. Vossen, Jean Donadieu
Journal: Blood
Blood (2021) 138 (Supplement 1): 4310.
https://doi.org/10.1182/blood-2021-153346
Published: 2021
Journal Articles

Mavorixafor, an Oral CXCR4 Antagonist, for Treatment of Patients with WHIM Syndrome: Results from the Long-Term Extension of the Open-Label Phase 2 Study

David C. Dale, Frank Caleb Firkin, Audrey Anna Bolyard, Weihua Tang, Honghua Jiang, Richard MacLeod, Diego Cadavid, Yanping Hu
Journal: Blood
Blood (2021) 138 (Supplement 1): 1121.
https://doi.org/10.1182/blood-2021-145759
Published: 2021
Journal Articles

Preliminary Clinical Response Data from a Phase 1b Study of Mavorixafor in Combination with Ibrutinib in Patients with Waldenström's Macroglobulinemia with MYD88 and CXCR4 Mutations

Steven P. Treon, Christian Buske, Sheeba K Thomas, Jorge J. Castillo, Andrew R. Branagan, Meletios A. Dimopoulos, Maria Gavriatopoulou, Diego Cadavid, Felix T Garzon, Weihua Tang, Sean Seyffert, Varun Garg, Shariq Ali, Arthur G. Taveras, Kelly Chen, Jeffrey V. Matous
Journal: Blood
Blood (2021) 138 (Supplement 1): 1362.
https://doi.org/10.1182/blood-2021-144706
Published: 2021
Journal Articles

Oral Administration of Mavorixafor, a CXCR4 Antagonist, Increases Peripheral White Blood Cell Counts across Different Disease States

David C. Dale, Steven P. Treon, David F. McDermott, Diego Cadavid, Xia Luo, Varun Garg, Weihua Tang, Honghua Jiang, Kelly Chen, Arthur G. Taveras, Ashish Bhandari, Jean Donadieu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2186.
https://doi.org/10.1182/blood-2021-152990
Published: 2021
Journal Articles

Induction of Fetal Hemoglobin By FTX6058, a Novel Small Molecule Development Candidate

Peter Rahl, Ivan Efremov, Billy Stuart, Keqiang Xie, Mark Roth, Richard Barnes, Kingsley Appiah, David Peters, Qingyi Li, Steven Kazmirski, Paul Bruno, Kim Stickland, Lucienne Ronco, Diego Cadavid, Lorin Thompson, Owen Wallace, Christopher Moxham
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-142056
Published: 2020